Matthew Dellavedova holds a substantial edge in the ITF M25 Taipei round-of-16 matchup, driven by his higher ATP ranking near 309 and greater experience on the professional circuit compared with Jeffrey Chuan En Hsu’s lower-tier profile. Dellavedova’s recent activity includes Australian Open qualifying appearances and consistent ITF/Challenger results, while Hsu enters off a straight-sets loss in a prior M25 event and limited top-level exposure. Surface conditions on hard courts in Taipei favor Dellavedova’s baseline game and physical attributes. Trader consensus reflects this disparity through heavy favorite pricing for the Australian, though lower-ranked players can produce upsets when form or fatigue intervenes on the ITF circuit.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedJeffrey Chuan En Hsu – Matthew Dellavedova
Moneyline
$23 Vol.
This market will resolve to 'Jeffrey Chuan En Hsu' if Jeffrey Chuan En Hsu advances against Matthew Dellavedova.
This market will resolve to 'Matthew Dellavedova' if Matthew Dellavedova advances against Jeffrey Chuan En Hsu.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one player advances due to the opponent's retirement, default, or disqualification, this market will resolve to the player who advances.
If the match ends in a walkover (player withdraws before the start and the other advances automatically), this market will resolve to 50-50.
The primary resolution source will be official information from the International Tennis Federation (ITF). A consensus of credible reporting may also be used.
Market Opened: Aug 18, 2026, 8:14 AM ET
Resolution Source
https://www.itftennis.com/en/tournament-calendar/Resolver
0x65070BE91...Jeffrey Chuan En Hsu – Matthew Dellavedova
Moneyline
$23 Vol.
This market will resolve to 'Jeffrey Chuan En Hsu' if Jeffrey Chuan En Hsu advances against Matthew Dellavedova.
This market will resolve to 'Matthew Dellavedova' if Matthew Dellavedova advances against Jeffrey Chuan En Hsu.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one player advances due to the opponent's retirement, default, or disqualification, this market will resolve to the player who advances.
If the match ends in a walkover (player withdraws before the start and the other advances automatically), this market will resolve to 50-50.
The primary resolution source will be official information from the International Tennis Federation (ITF). A consensus of credible reporting may also be used.
Market Opened: Aug 18, 2026, 8:14 AM ET
Resolution Source
https://www.itftennis.com/en/tournament-calendar/Resolver
0x65070BE91...Matthew Dellavedova holds a substantial edge in the ITF M25 Taipei round-of-16 matchup, driven by his higher ATP ranking near 309 and greater experience on the professional circuit compared with Jeffrey Chuan En Hsu’s lower-tier profile. Dellavedova’s recent activity includes Australian Open qualifying appearances and consistent ITF/Challenger results, while Hsu enters off a straight-sets loss in a prior M25 event and limited top-level exposure. Surface conditions on hard courts in Taipei favor Dellavedova’s baseline game and physical attributes. Trader consensus reflects this disparity through heavy favorite pricing for the Australian, though lower-ranked players can produce upsets when form or fatigue intervenes on the ITF circuit.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedBeware of external links.
Beware of external links.
Frequently Asked Questions
Build a combo
Select two options
Beware of external links.
Beware of external links.
Frequently Asked Questions